Want to see KR:068330 full AI Analyst Report?
ilShinbiobase Co., Ltd. (068330) Stock Price & Analysis
068330 Stock Chart & Stats
- Day’s Range
- KRW 978.00 - KRW 999.00
- 52-Week Range
- KRW 851.00 - KRW 2,055.00
- Previous Close
- KRW 1,001.00
- Volume
- N/A
- Average Volume (3M)
- 54.25K
- Market Cap
- KRW 41.72B
- Enterprise Value
- -KRW 5.41B
- Total Cash (Recent Filing)
- KRW 47.41B
- Total Debt (Recent Filing)
- KRW 0
- Price to Earnings (P/E)
- 10.2
- Beta
- 0.21
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Dec 29, 2025
- Dividend Yield
- 0.95%
Bulls Say, Bears Say
Bulls Say
High And Sustained Profitability
Persistently high gross and net margins indicate strong profitability across the reported period, while the 2025 EBIT margin remained robust. This gives the company room to absorb operating variability, reinvest in its business, and preserve earnings power over the coming quarters.
Near-zero Leverage And Financial Flexibility
A virtually debt-free balance sheet reduces interest burden and refinancing exposure, allowing more operating cash to remain available for investment or shareholder returns. Steady growth in assets and equity further supports resilience and financial flexibility through changing business conditions.
Generally Strong Earnings-to-cash Conversion
Operating cash flow generally keeping pace with net income supports the quality of reported profits and indicates that earnings are usually converting into liquidity. This provides a stronger foundation for funding operations and growth without relying heavily on external financing.
Bears Say
Uneven Revenue Trajectory
The history of multiple revenue declines shows that top-line performance has not followed a consistently compounding path. Although 2025 rebounded strongly, the uneven pattern suggests exposure to cyclical demand or contract timing, making future growth less predictable.
Recent Free-cash-flow Volatility
Recent deterioration in free cash flow weakens the otherwise strong earnings profile and may reduce internally generated funds available for investment or distributions. Continued volatility would make cash planning more difficult and could expose results to working-capital swings or lumpy spending.
Lower Recent Capital Efficiency And Earnings
Moderating return on equity indicates that the company has recently converted its growing equity base into profits less efficiently than before. Combined with earnings easing after the 2023 peak, this creates a risk that profitability may not sustain its earlier level without renewed operating momentum.
068330 FAQ
What was ilShinbiobase Co., Ltd.’s price range in the past 12 months?
What is ilShinbiobase Co., Ltd.’s market cap?
When is ilShinbiobase Co., Ltd.’s upcoming earnings report date?
How were ilShinbiobase Co., Ltd.’s earnings last quarter?
Is ilShinbiobase Co., Ltd. overvalued?
Does ilShinbiobase Co., Ltd. pay dividends?
What is ilShinbiobase Co., Ltd.’s EPS estimate?
How many shares outstanding does ilShinbiobase Co., Ltd. have?
What happened to ilShinbiobase Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ilShinbiobase Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
ilShinbiobase Co., Ltd.
Operating out of South Korea, ilShinbiobase Co Ltd specializes in producing industrial-grade equipment for both refrigeration and freezing purposes.
- Sector
- General
- Industry
- Industrial - Machinery
- CEO
- Sung-Dae Hong
ilShinbiobase Co., Ltd. (068330) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 6 | 15 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 0 | 0 | 12 |
